FDA Clears Neurovascular Retriever for Use in Stroke Patients
August 30, 2007 - Concentric Medical announces that it has obtained FDA 510(k) clearance for its Merci L6 Retriever, a device that restores blood flow to ischemic stroke patients, adding to its line of four other Merci Retrievers on the market.
The Merci Retriever is designed to restore blood flow by engaging, capturing and removing blood clots. It is a shaped wire constructed of nitinol, a memory wire, which allows delivery of the Retriever in linear form using standard catheterization techniques. A small puncture in the groin is used to introduce the Merci Retriever into an artery leading to the brain. Upon reaching the targeted area, the Retriever returns to its original shape when deployed. The Merci L6 Retriever joins the L family of retrievers, incorporating a 2.7 mm cylindrical helix with attached filaments. The filaments provide an additional mechanism for securing the clot during retrieval. This new design is targeted at larger vessels than the existing Merci Retrievers.
For more information: www.concentric-medical.com
More like this
- FDA Clears Neurovascular Retriever for Use in Stroke Patients
- Study Finds Intra-Aortic Balloon Pump Therapy May Not be Useful in STEMI Patients
- Trends and Advances in Hemodynamic Support
- Heart Failure Cardiac Assist Device Uses Transcutaneous Energy
- FDA Develops Regulations for Intra-aortic Balloon Pumps 40 Years After Their Introduction